Bellevue Group AG - QIAGEN NV ownership

QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 191 filers reported holding QIAGEN NV in Q4 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of QIAGEN NV
ValueSharesWeighting
Q1 2017$2,302,000
-10.2%
79,444
-13.2%
0.31%
-41.5%
Q4 2016$2,564,000
+2.1%
91,5000.0%0.52%
+15.6%
Q3 2016$2,511,000
+25.8%
91,5000.0%0.45%
+20.7%
Q2 2016$1,996,000
-2.3%
91,5000.0%0.38%
+1.3%
Q1 2016$2,044,00091,5000.37%
Other shareholders
QIAGEN NV shareholders Q4 2016
NameSharesValueWeighting ↓
Hardman Johnston Global Advisors LLC 6,178,402$170,833,00011.32%
Tikvah Management LLC 369,425$10,215,0005.35%
BLUE JAY CAPITAL MANAGEMENT, LLC 360,000$9,954,0003.36%
Opus Point Partners Management, LLC 160,000$4,424,0002.92%
Exane Asset Management 106,238$2,910,304,0001.76%
Douglas C. Lane & Associates, Inc. 1,918,338$53,042,0001.44%
Granahan Investment Management 1,051,000$29,060,0001.00%
CRAMER ROSENTHAL MCGLYNN LLC 2,285,569$63,196,0000.95%
Sivik Global Healthcare LLC 70,000$1,936,0000.92%
PURA VIDA INVESTMENTS, LLC 78,668$2,175,0000.92%
View complete list of QIAGEN NV shareholders